New Zealand markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.77+0.10 (+0.73%)
At close: 04:00PM EDT
13.79 +0.02 (+0.15%)
After hours: 06:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 43.77B
Enterprise value 72.20B
Trailing P/E 46.50
Forward P/E 17.09
PEG ratio (5-yr expected) 0.71
Price/sales (ttm)1.57
Price/book (mrq)0.92
Enterprise value/revenue 2.60
Enterprise value/EBITDA 12.33

Trading information

Stock price history

Beta (5Y monthly) 0.50
52-week change 3-9.76%
S&P500 52-week change 318.96%
52-week high 316.39
52-week low 312.58
50-day moving average 313.23
200-day moving average 313.90

Share statistics

Avg vol (3-month) 31.68M
Avg vol (10-day) 32.72M
Shares outstanding 53.17B
Implied shares outstanding 63.18B
Float 81.55B
% held by insiders 10.01%
% held by institutions 12.49%
Shares short (15 Jul 2024) 47.13M
Short ratio (15 Jul 2024) 43.84
Short % of float (15 Jul 2024) 4N/A
Short % of shares outstanding (15 Jul 2024) 40.20%
Shares short (prior month 14 Jun 2024) 47.61M

Dividends & splits

Forward annual dividend rate 40.58
Forward annual dividend yield 44.24%
Trailing annual dividend rate 3188.00
Trailing annual dividend yield 31,375.27%
5-year average dividend yield 44.72
Payout ratio 4201.60%
Dividend date 308 Jul 2024
Ex-dividend date 427 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.38%
Operating margin (ttm)4.89%

Management effectiveness

Return on assets (ttm)2.12%
Return on equity (ttm)2.12%

Income statement

Revenue (ttm)4.26T
Revenue per share (ttm)1,362.70
Quarterly revenue growth (yoy)9.90%
Gross profit (ttm)N/A
EBITDA 1.14T
Net income avi to common (ttm)144.07B
Diluted EPS (ttm)0.30
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)457.8B
Total cash per share (mrq)291.78
Total debt (mrq)5.46T
Total debt/equity (mrq)75.11%
Current ratio (mrq)1.11
Book value per share (mrq)4,635.56

Cash flow statement

Operating cash flow (ttm)716.34B
Levered free cash flow (ttm)115.51B